Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE)-- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...

Nvidia sold its entire 7.71 million share stake in Recursion Pharmaceuticals by December 31, 2025 Recursion stock swung 14% lower intraday Wednesday before closing 2% higher ARK Invest bought 1.25 ...

As Immigration and Customs Enforcement was racing to add 10,000 new officers to its force, an artificial intelligence error in how their applications were processed ...

(NEXSTAR) – States have two years to dramatically reduce mistakes in administering food aid or risk losing funding. The Trump administration has told states if they ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Thanks to the IRS MATH Act, the IRS must now explain mistakes in plain English, show any adjustments, and put your 60-day appeal deadline front and center. It will be a major upgrade from previously ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

The Senate this week passed a bill to fix IRS math error notices for filers who make simple mistakes on their tax returns. The Internal Revenue Service Math and ...